Search Results - "DI FRONZO, Giovanni"

Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line by Biffi, A, Coradini, D, Larsen, R, Riva, L, Di Fronzo, G

“…In vivo and in vitro studies have shown an antitumor activity of Lactobacilli in colon cancer, and some epidemiologic studies have indicated a reduced risk of…”
Get full text

Time-Dependent Relevance of Steroid Receptors in Breast Cancer by CORADINI, D, DAIDONE, M. G, BORACCHI, P, BIGANZOLI, E, ORIANA, S, BRESCIANI, G, PELLIZZARO, C, TOMASIC, G, DI FRONZO, G, MARUBINI, E

“…To analyze the time-dependent prognostic role of the investigated variables, considered, when appropriate, on a continuous scale, for the purpose of evaluating…”
Get full text

Laminin receptors, collagenase IV and prognosis in node-negative breast cancers by Daidone, M G, Silvestrini, R, D'Errico, A, Di Fronzo, G, Benini, E, Mancini, A M, Garbisa, S, Liotta, L A, Grigioni, W F

“…In 187 node-negative breast cancers, the expression of laminin receptors and collagenase IV was directly related in 52% of cases, independently of pathological…”
Get more information

P53 accumulation in primary breast cancer: a comparison between immunohistochemistry and a novel luminometric immunoassay by Bombardieri, E, Seregni, E, Daidone, M G, Benini, E, Massaron, S, Ferrari, L, Di Fronzo, G, Silvestrini, R

“…The accumulation of p53 protein was evaluated by a novel luminometric immunoassay (LIA) in cytosol samples from a series of 245 primary breast cancers. The…”
Get more information

Modulation of estrogen receptor-β isoforms by phytoestrogens in breast cancer cells by CAPPELLETTI, Vera, MIODINI, Patrizia, DI FRONZO, Giovanni, DAIDONE, Maria Grazia

“…High consumption of phytoestrogen-rich food correlates with reduced incidence of breast cancer. However, the effect of phytoestrogens on growth of pre-existing…”
Get full text

The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients by Silvestrini, R, Veneroni, S, Daidone, M G, Benini, E, Boracchi, P, Mezzetti, M, Di Fronzo, G, Rilke, F, Veronesi, U

“…The bcl-2 gene (also known as BCL2) encodes for a mitochondrial protein thought to prevent apoptosis of normal cells. The protein has been detected by…”
Get more information

Genistein in the control of breast cancer cell growth: insights into the mechanism of action in vitro by Fioravanti, Laura, Cappelletti, Vera, Miodini, Patrizia, Ronchi, Enrico, Brivio, Moreno, Di Fronzo, Giovanni

“…Genistein significantly inhibited cell growth (IC 50 around 10 μM) of MCF-7, MDAMB-231 and HBL-100 cell lines, but not of skin-derived fibroblasts and…”
Get full text

p53 as an independent prognostic marker in lymph node-negative breast cancer patients by Silvestrini, R, Benini, E, Daidone, M G, Veneroni, S, Boracchi, P, Cappelletti, V, Di Fronzo, G, Veronesi, U

“…At present, most decisions concerning the use of adjuvant therapy in lymph node-negative breast cancer patients are made on the basis of traditional factors…”
Get more information

Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more by Bonadonna, G, Veronesi, U, Brambilla, C, Ferrari, L, Luini, A, Greco, M, Bartoli, C, Coopmans de Yoldi, G, Zucali, R, Rilke, F

“…In 165 women with breast cancer who were candidates for mastectomy because the largest diameter of the tumor was 3 cm or more, we administered primary…”
Get more information

Correlations between cytotoxicity, biochemical effects, drug levels, and therapeutic effectiveness of daunomycin and adriamycin on Sarcoma 180 ascites in mice by Silvestrini, R, Lenaz, L, Di Fronzo, G, Sanfilippo, O

Get full text

Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer by Silvestrini, R, Daidone, M G, Luisi, A, Boracchi, P, Mezzetti, M, Di Fronzo, G, Andreola, S, Salvadori, B, Veronesi, U

“…We evaluated, in 1,800 patients with node-negative tumors treated with locoregional therapy until relapse, the competitive risks for different types of…”
Get more information

int‐2 Oncogene amplification and prognosis in node‐negative breast carcinoma by Fioravanti, Laura, Cappelletti, Vera, Coradini, Danila, Miodini, Patrizia, Borsani, Giorgio, Daidone, Maria Grazia, Di Fronzo, Giovanni

“…The role of int‐2 oncogene amplification on the prognosis of breast cancer patients was investigated in 128 patients with node‐negative primary breast cancers…”
Get full text

Effect of steroid receptors, pS2 and cathepsin D on the outcome of elderly breast cancer patients: An exploratory investigation by Coradini, Danila, Biganzoli, Elia, Boracchi, Patrizia, Bombardieri, Emilio, Seregni, Ettore, De Palo, Giuseppe, Martelli, Gabriele, Di Fronzo, Giovanni

“…In 83 elderly breast cancer patients, oestrogen and progesterone receptors (ER, PgR), pS2 and cathepsin D (CathD) were evaluated for their possible prognostic…”
Get full text

Simultaneous but not sequential treatment with sodium butyrate improves the antiproliferative effect of alpha- or beta-interferon on a breast cancer cell line by Biffi, A, Coradini, D, Pellizzaro, C, Pirronello, E, Di Fronzo, G

“…Clinical evidence indicates that alpha- and beta-interferon (alpha-IFN, beta-IFN) are only partially effective in human breast cancer. To improve their…”
Get more information

Combined effect of tamoxifen or interferon-beta and 4-hydroxyphenylretinamide on the growth of breast cancer cell lines by Coradini, D, Biffi, A, Pellizzaro, C, Pirronello, E, Di Fronzo, G

“…To improve the effectiveness of 4-hydroxyphenylretinamide (4-HPR), an analogue of retinoic acid used in chemoprevention and treatment of breast cancer, we…”
Get more information

Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer by SILVESTRINI, R, DAIDONE, M. G, DIFRONZO, G, MORABITO, A, VALAGUSSA, P, BONADONNA, G

“…The paper analyzes the relation among tumor size (T), estrogen receptor (ER) status, and labeling index (LI) and their relative merits in predicting the…”
Get full text

Effect of liposome-encapsulated alpha- or beta-interferon on breast cancer cell lines by Coradini, D, Pellizzaro, C, Biffi, A, Lombardi, L, Pirronello, E, Riva, L, Di Fronzo, G

“…Experimental evidence and clinical studies have indicated that interferons (IFN) inhibit proliferation in a wide panel of neoplasms, including breast cancer…”
Get more information

Cell kinetics as a predictive factor in node-positive breast cancer treated with adjuvant hormone therapy by Silvestrini, R, Daidone, M G, Mastore, M, Di Fronzo, G, Coradini, D, Boracchi, P, Squicciarini, P, Salvadori, B, Veronesi, U

“…The fraction of cells that incorporate 3H-thymidine (3H-dT labeling index [3H-dT LI]) proved to be a prognostic indicator in patients with node-negative and…”
Get more information

Estrogen-receptor status of patients who underwent mastectomy for breast cancer with a disease-free interval of not less than 8 years by BASSO RICCI, S, CORADINI, D, DI FRONZO, G, BARTOLI, C, VILLA, S

“…The authors present a series of 1,226 patients who underwent total or partial mastectomy for breast cancer, who for a period of no less than 8 years from…”
Get full text

Expression of the kidney-associated differentiation glycoprotein gp160 and resistance to the antitumor effects of interferon alpha in renal cell carcinomas by Geng, Y, Biffi, A, Engelstein, D, Ronch, E, Faustini, M, Lai, H K, Albino, A P, Di Fronzo, G, Nanus, D M

“…Alpha interferon (IFN-alpha) is commonly used to treat patients with advanced renal cell carcinoma (RCC). We previously reported that resistance of RCCs to…”
Get more information